CRIS Current Research Information System

GIANNELLA, MADDALENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.538
NA - Nord America 13.307
EU - Europa 10.936
SA - Sud America 909
AF - Africa 637
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 7
Totale 40.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.008
IT - Italia 4.281
SG - Singapore 4.030
CN - Cina 3.845
VN - Vietnam 3.199
GB - Regno Unito 1.732
DE - Germania 959
SE - Svezia 946
HK - Hong Kong 873
BR - Brasile 600
FR - Francia 597
IN - India 591
KR - Corea 575
NL - Olanda 464
RU - Federazione Russa 444
BD - Bangladesh 400
IE - Irlanda 317
JP - Giappone 294
FI - Finlandia 243
CI - Costa d'Avorio 225
ZA - Sudafrica 158
CA - Canada 151
AR - Argentina 133
BG - Bulgaria 126
UA - Ucraina 115
AT - Austria 111
ID - Indonesia 105
CH - Svizzera 101
EE - Estonia 96
ES - Italia 90
PH - Filippine 76
JO - Giordania 71
PL - Polonia 69
IQ - Iraq 68
MX - Messico 68
TG - Togo 64
TR - Turchia 64
BE - Belgio 63
TH - Thailandia 63
AU - Australia 55
TW - Taiwan 43
NG - Nigeria 42
SA - Arabia Saudita 40
SC - Seychelles 38
PE - Perù 36
PK - Pakistan 36
CL - Cile 33
EC - Ecuador 31
CO - Colombia 29
MY - Malesia 29
RO - Romania 26
EG - Egitto 25
UZ - Uzbekistan 23
IR - Iran 22
GR - Grecia 21
LT - Lituania 21
PY - Paraguay 20
HR - Croazia 18
JM - Giamaica 16
PT - Portogallo 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
MA - Marocco 15
KE - Kenya 14
AZ - Azerbaigian 12
DZ - Algeria 12
HN - Honduras 11
RS - Serbia 11
DK - Danimarca 10
AL - Albania 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
CR - Costa Rica 7
LB - Libano 7
LY - Libia 7
MD - Moldavia 7
PA - Panama 7
HU - Ungheria 6
IL - Israele 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
CZ - Repubblica Ceca 5
ET - Etiopia 5
GT - Guatemala 5
KH - Cambogia 5
KZ - Kazakistan 5
NP - Nepal 5
NZ - Nuova Zelanda 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
FJ - Figi 4
KG - Kirghizistan 4
MK - Macedonia 4
MM - Myanmar 4
PR - Porto Rico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
Totale 40.321
Salva come PNG Salva come JPEG
Città #
Singapore 2.836
Ashburn 1.625
Southend 1.450
Hefei 1.226
Fairfield 1.015
San Jose 926
Hong Kong 808
Ho Chi Minh City 779
Chandler 774
Hanoi 675
Bologna 625
Santa Clara 534
Seoul 527
Woodbridge 475
Wilmington 441
Seattle 431
Houston 412
Boardman 387
Beijing 383
New York 378
Cambridge 360
Milan 334
Princeton 320
Ann Arbor 316
Dublin 313
Rome 296
Dallas 262
Tokyo 256
Los Angeles 242
Council Bluffs 232
Abidjan 225
Lauterbourg 218
Dong Ket 204
Helsinki 159
Bengaluru 128
Buffalo 123
Sofia 121
Berlin 117
Westminster 112
Nanjing 108
Da Nang 107
Redondo Beach 104
Padova 99
Turin 99
São Paulo 98
Frankfurt am Main 93
Chicago 92
Haiphong 87
Florence 86
Munich 85
Shanghai 82
Naples 80
Saint Petersburg 75
Amman 69
Jakarta 69
Bern 67
Guangzhou 66
Lomé 64
Vienna 64
Redmond 61
San Diego 61
Falls Church 59
Jinan 59
Lappeenranta 58
Shenyang 58
Amsterdam 57
Nuremberg 57
Modena 56
Bremen 53
Brussels 52
Warsaw 50
London 49
San Francisco 48
Toronto 47
Genoa 46
Montreal 45
The Dalles 43
Castel Maggiore 40
Hải Dương 39
Orem 39
Hebei 38
Johannesburg 38
Rimini 38
Verona 38
Phoenix 37
Can Tho 36
Nanchang 36
Palermo 36
Paris 36
Changsha 35
Dearborn 35
Des Moines 35
Biên Hòa 34
Denver 34
Tongling 34
Abeokuta 33
Baghdad 33
Redwood City 33
Catania 32
Falkenstein 30
Totale 24.517
Salva come PNG Salva come JPEG
Nome #
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 1.060
Caratterizzazione fenotipica e genotipica di ceppi di Staphylococcus aureus isolati in corso di batteriemia 800
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 560
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 328
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 328
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 316
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 294
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 274
Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup 274
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 261
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 256
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 254
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 254
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 252
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 249
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 248
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 238
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 234
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 229
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 226
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 224
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 223
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 220
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 216
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 215
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 212
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery 211
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 211
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 209
Invasive candidiasis due to candida norvegensis in a liver transplant patient: Case report and literature review 207
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 205
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 204
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 202
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 201
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 201
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 201
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 199
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 198
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 198
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 196
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 193
Advances in the therapy of bacterial bloodstream infections 193
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 192
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 190
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 190
Bloodstream infections in patients with liver cirrhosis 188
Impact of preoperative infection on outcome after liver transplantation 188
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 188
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 187
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 187
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 184
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 184
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 183
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 183
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit 180
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 180
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 178
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 178
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 177
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 176
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study 176
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 174
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 172
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 171
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 171
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 169
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 168
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 167
Diffuse primary cutaneous infection by Alternaria alternata in a liver transplant recipient with pulmonary nocardiosis: Importance of prompt identification for clinical resolution 167
Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis 166
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 166
Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program 166
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 166
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 165
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 165
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 164
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 164
Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae 162
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 162
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 160
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2 159
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 159
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 159
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 159
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 159
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 158
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 158
The Gut Microbiota of Critically Ill Patients With COVID-19 157
CMV-RNAemia as new marker of active viral replication in transplant recipients 156
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 156
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 156
LA CONTAMINAZIONE DEL LIQUIDO DI PERFUSIONE DELL’ORGANO NEL TRAPIANTO DI FEGATO:INCIDENZA, PROFILO MICROBIOLOGICO ED IMPATTO CLINICO. 155
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 155
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 155
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar? 154
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review 153
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? 153
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 153
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 153
Totale 21.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021675 0 0 0 0 0 0 0 0 0 0 0 675
2021/20223.310 228 100 160 269 272 208 124 270 170 379 540 590
2022/20233.795 336 412 201 496 356 303 141 255 683 173 233 206
2023/20242.053 148 243 154 189 170 322 157 138 92 165 125 150
2024/20256.982 241 759 535 566 796 385 545 301 236 559 744 1.315
2025/202618.320 1.600 2.035 1.663 1.403 1.613 870 1.950 594 3.169 1.281 1.203 939
Totale 41.305